4
Changes in Ownership
Immunocore Holdings plc Filed Acc 0001415889-24-006079
HEAD OF R&D sold 36,509 shares at an average $68.59 ($2,504,158)
- HEAD OF R&D acquired 36,509 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Berman David M HEAD OF R&D | 2024-02-28 | Option exercise 10b5-1 | +36,509 | $17.46 | $637,447 | 36,509 | D |
| Berman David M HEAD OF R&D | 2024-02-28 | Sale 10b5-1 | −16,900 | $67.61 | $1,142,609 | 19,609 | D |
| Berman David M HEAD OF R&D | 2024-02-28 | Sale 10b5-1 | −7,472 | $68.84 | $514,372 | 12,137 | D |
| Berman David M HEAD OF R&D | 2024-02-28 | Sale 10b5-1 | −10,937 | $69.73 | $762,637 | 1,200 | D |
| Berman David M HEAD OF R&D | 2024-02-28 | Sale 10b5-1 | −1,200 | $70.45 | $84,540 | 0 | D |
| Derivatives | |||||||
| Berman David M HEAD OF R&D | 2024-02-28 | Option exercise · Employee Share Option (Right to Buy) 10b5-1 | −36,509 | 271,790 | D | ||
| Open-market sales · 36,509 sh · avg $68.59 · $2,504,158 | |||||||
Loading xslF345X05/form4-03012024_040305.xml…